Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Clown-Free Zone... sorry, no clowns allowed -- Ignore unavailable to you. Want to Upgrade?

To: pater tenebrarum who wrote (39478)	11/20/2000 7:19:55 PM
From: AllansAlias	Respond to of 436258

I see. Yes.

To: pater tenebrarum who wrote (39478)	11/25/2000 1:42:57 PM
From: Spekulatius	Read Replies (1) \| Respond to of 436258

Heinz,have you looked at buying some Biotechs recently? I like some smaller Biotech's with a low market cap and valuable IP or state of the art research as well as some well capitalized player in the genomics field. Many of the bi players are still very richly valued (HGSI, MLNM) but a lot of small caps are still value stocks, in terms of the valuation of their IP and research programs. The sector has changed and an enormous amount of cash has been raised (35B$!),so its unlikely, that the Biotech stocks will retreat to the levels seen in 1998.